Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide

Bioconjugate Chemistry

Volumn 10, Issue 3, 1999, Pages 431-438

  Decristoforo, Clemens ^a   Mather, Stephen J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATION; INDIUM COMPOUNDS; ISOMERS; PEPTIDES; STEREOCHEMISTRY;

ADIPATES; BI-FUNCTIONAL; BINDING AFFINITIES; CO-LIGANDS; IN-VITRO; LABELINGS; LIPOPHILICITY; OCTREOTIDE; SMALL SCALE; VITRO CHARACTERIZATION;

BINDING ENERGY;

(BENZOYLTHIO)ACETYLTRIGLYCINE; ANTINEOPLASTIC AGENT; CHELATING AGENT; CROSS LINKING REAGENT; DRUG DERIVATIVE; GLYCINE; HYDRAZINE DERIVATIVE; HYDRAZINO NICOTINAMIDE; NICOTINAMIDE; OCTREOTIDE; S-BENZOYLMERCAPTOACETYLTRIGLYCINE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; TECHNETIUM; TYROSINE; VAPREOTIDE;

ANIMAL; ARTICLE; BINDING COMPETITION; CELL LINE; CHEMISTRY; HUMAN; IN VITRO STUDY; METABOLISM; MOUSE; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BINDING, COMPETITIVE; CELL LINE; CHELATING AGENTS; CROSS-LINKING REAGENTS; GLYCINE; HUMANS; HYDRAZINES; MICE; NIACINAMIDE; OCTREOTIDE; RATS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TECHNETIUM; TYROSINE;

EID: 0032587086     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc980121c     Document Type: Article

References (33)

1. Eising, E. G., Bier, D., Knust, E. J., and Reinere, C. (1996) Somatostatin-receptor scintigraphy. Methods, indications, results. Radiologe 36, 81-88.
2. Lamberts, S. W., Chayvialle, J. A., and Krenning, E. P. (1993) The visualization of gastroenteropancreatic endocrine tumors. Digestion 54 (Suppl. 1), 92-97.
3. Vekemans, M. C., Urbain, J. L., and Charkes, D. (1995) Advances in radio-imaging of neuroendocrine tumors. Curr. Opin. Oncol 7, 63-67.
4. 123I-Tyr]octreotide: The Rotterdam experience with more than 1000 patients Eur. J. Nucl. Med. 20, 716-731.
5. Srkalovic, G., Cai, R. Z., and Schally, A. V. (1990) Evaluation of receptors for somatostatin in various tumors using different analogues. J. Clin. Endocrinol. Metab. 70, 661-669.
6. Liebow, C., Reilly, C., Serrano, M., and Schally, A. V. (1989) Somatostain analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. U.S.A. 86, 2003-2007.
7. Pinski, J., Milovanovic, T. Y., Yano, T., Hamaoui, A., Radulovic, S., Cai, R. Z., and Schally, A. V. (1992) Biological activity and receptor binding characteristics to various human tumors of acetylated somatostatin receptors. Proc. Soc. Exp. Biol. Med 200, 49-56.
8. Banks, W. A., Schally, A. V., Barrera, C. M., Fasold, M. B., Durham, D. A., Csernus, V. J., and Kastin, A. J. (1990) Permeability of the murine blood brain barrier to some octapeptide analogues of somatostatin. Proc. Natl. Acad. Sci. U.S.A. 87, 6762-6766.
9. 3]octreotide. Eur. J. Nucl. Med. 20, 1089-1094.
10. Breeman, W. A. P., Hofland, L. J., Pluijm, M.van-der, van Koetsveld, P. M., de Jong, M., Setyono-Han, B., Bakker, W. H., Kweekeboom, D. J., Visser, T. J., Lamberts, S. W. J., and Krenning, E. P. (1994) A new radiolabeled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide. Eur. J. Nucl. Med. 21, 328-335.
11. Zamora, P. O., Gulhke, S., Bender, H., Diekmann, D., Rhodes, B. A., Biersack, H. J., and Knapp, F. F., Jr. (1996) Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with 188Re-RC-160, a directly radiolabeled somatostatin analogue. Int. J. Cancer 65, 214-20.
12. Liu, S., Edwards, D. S., and Barrett, J. A. (1997) 99mTc labeling of highly potent small peptides. Bioconjugate Chem. A, 621-636.
13. Valabhajosula, S., Moyer, B. R., Lister-James, J., McBride, B. J., Lipszyk, H., Lee, H., Bastidas, D., and Dean, R. T. (1996) Preclinical evaluation of Technetium-99m-Labeled Somatostatin Receptor-Binding Peptides. J. Nucl. Med. 37, 1016-1022.
14. Maina, T., Stolz, B., Albert, R., Bruns, C., Koch, P., and Mäcke, H. (1994). Synthesis and biological evaluation of a new somatostatin analogue (SDZ 219-387) labeled with technetium-99m. Eur. J. Nucl. Med. 21, 437-444.
15. Maina, T., Stolz, B., Albert, R., Nock, B., Bruns, C., and Macke, H. (1995) Synthesis, radiochemistry and biological evaluation of 99mTc[N4-(D)PHE1]-octreotide, a new octreotide derivative with high affinity for somatostatin receptors, in Technetium and Rhenium in Chemistry and Nuclear Medicine 4 (M. Nicolini, G. Banoli, and U. Mazzi, Eds.) pp 395-400, SG Editorali, Padova.
16. Macke, H. R. and Behe, M. (1996) New octreotide derivatives labeled with technetium-99m. J. Nucl. Med. 37, 29P (abstr 107).
17. Thakur, M. L., Kolan, H., Wiaderkiewicz, R., Pallela, V. R., Duggaraju, R., and Schally, A. V. (1997) Radiolabeled Somatostatin analogues in Prostate Cancer. Nucl. Med. Biol. 24, 105-113.
18. Kolan, H., Li, J., and Thakur, M. L. (1996) Sandostatin Labeled with 99mTc: In Vitro Stability, In Vivo Validity and Comparison with 111In-DTPA-Octreotide. Peptide Res. 9, 144-150.
19. Abrams, M. J., Juweid, M., tenKate, C. I., Schwartz, D. A., Hauser, M. M., Gaul, F. E., Fuccello, A. J., Rubin, R. H., Strauss, H. W., and Fischman, A. J. (1990) Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J. Nucl. Med. 31, 2022-2028.
20. Kasina, S., Sanderson, J. A., Fitzner, J. N., Srinivasan, A., Rao, T. N., Hobson, L. J., Reno, J. M., Axworthy, D. B., Beaumier, P. L., and Fritzberg, A. R. (1998) Simplified preformed chelate protein radiolabeling with technetium-99m nercaptoaceta-midoadipoylglycylglycine (N3S-Adipate). Bioconjugate Chem. 9, 108-117.
21. Hnatowich, D. J., Qu, T., Chang, F., Ley, A. C., Ladner, R. C., and Rusckowski, M. (1998) Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine. J. Nucl. Med. 39, 56-64.
22. Hnatowich, D. J., Virzi, F., Fogorasi, M., Rusckowski, M., and Winnard, P. (1994) Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies. Nucl. Med. Biol. 21, 1035-1044.
23. Stalteri, M. A., Bansal, S., Hider, R., and Mather, S. J. (1999) Comparison of the stability of technetium labeled peptides to challenge with cysteine. Bioconjugate Chem. 10, 130-136.
24. Hofland, L. J., van Knoetsveld, P. M., Wouters, N., Waaijers, M., Reubi, J. C., and Lamberts, S. W. J. (1992) Dissociation of antiproliferative and antihormoral effects of somatostatin analogue octreotide on 7315b pituitary tumor cells. Endocrinology 131, 571-577.
25. Hofland, L. J., van Knoetsveld, P. M., Waaijers, M., and Lamberts, S. W. (1996) Internalisation of isotope-coupled somatostatin analoges. Digestion 57 (Suppl. 1), 2-6.
26. Taylor, J. E., Theveniau, M. A., Bashirzadeh, R., Reisine, T., and Eden, P. A. (1994) Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SST2 heterogeneity. Peptides 15, 1229-1236.
27. Liu, S., Edwards, D. S., Looby, R. J., Harris, A. R., Poirier, M. J., Barrett, J. A., Heminway, S. J., and Carroll, T. R. (1996) Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands. Bioconjugate Chem. 7, 63-71.
28. Edwards, D. S., Liu, S., Barrett, J. A., Harris, A. R., Looby, R J., Ziegler, M. C., Heminway, S. J., and Carroll, T. R. (1997) New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modifies cyclic glycoprotein Iib/IIIa receptor antagonist with 99mTc. Bioconjugate Chem. 8, 146-154.
29. 99mTc-labeling of hydrazio nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands, Bioconjugate Chem. 9, 583-595.
30. 99mTc-Mercaptoacetyltriglycine. Nucl. Med. Biol. 22, 339-349.
31. 99mTc-MAG3. Eur. J. Nucl. Med. 16, 615-619.
32. Noll, B., Johannsen, B., and Spies, H. (1995) Sources of radiochemical impurities in the 99mTc/S-unprotected MAG3 system. Nucl. Med. Biol. 22, 1057-1062.
33. 0]octreotide. Eur. J. Nucl. Med. 25, 182-186.